Cingulate Inc是一家临床阶段的生物制药公司。该公司专注于利用精确定时释放（PTR）药物输送平台技术开发，制造和商业化药品 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

KANSAS CITY, Kan., April 29, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery ...

1,2 Developmentally, the executive attention network- which includes the anterior cingulate cortex and anterior insula- underpins effortful control and is critical for task management. While this ...

Cingulate has a 52 week low of $1.80 and a 52 week high of $20.83. The firm’s 50-day simple moving average is $4.01 and its 200 day simple moving average is $4.32. Hedge Funds Weigh In On Cingulate ...